Aspirin for the next generation

First used as an analgesic and antipyretic, investigations into aspirin’s anti-inflammatory effects led to its establishment in 1974 as a drug that altered the activity of platelets to influence the course and incidence of myocardial infarction and cerebrovascular disease. It became the standard in...

Descripción completa

Detalles Bibliográficos
Autores principales: Henderson, Nick, Smith, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2013
Materias:
Conference Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622499/
https://www.ncbi.nlm.nih.gov/pubmed/23589729
http://dx.doi.org/10.3332/ecancer.2013.300
_version_ 1782265841200398336
author Henderson, Nick
Smith, Tom
author_facet Henderson, Nick
Smith, Tom
author_sort Henderson, Nick
collection PubMed
description First used as an analgesic and antipyretic, investigations into aspirin’s anti-inflammatory effects led to its establishment in 1974 as a drug that altered the activity of platelets to influence the course and incidence of myocardial infarction and cerebrovascular disease. It became the standard in treatment and prevention of vascular disorders. The 25th International Scientific Meeting on aspirin held at the Royal College of Physicians in London on 24th October 2012 took aspirin into fresh fields, among them cancer, diabetes, dementia and gynaecology.
format Online
Article
Text
id pubmed-3622499
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Cancer Intelligence
record_format MEDLINE/PubMed
spelling pubmed-36224992013-04-15 Aspirin for the next generation Henderson, Nick Smith, Tom Ecancermedicalscience Conference Report First used as an analgesic and antipyretic, investigations into aspirin’s anti-inflammatory effects led to its establishment in 1974 as a drug that altered the activity of platelets to influence the course and incidence of myocardial infarction and cerebrovascular disease. It became the standard in treatment and prevention of vascular disorders. The 25th International Scientific Meeting on aspirin held at the Royal College of Physicians in London on 24th October 2012 took aspirin into fresh fields, among them cancer, diabetes, dementia and gynaecology. Cancer Intelligence 2013-04-02 /pmc/articles/PMC3622499/ /pubmed/23589729 http://dx.doi.org/10.3332/ecancer.2013.300 Text en © the authors; licensee ecancermedicalscience. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Conference Report
Henderson, Nick
Smith, Tom
Aspirin for the next generation
title Aspirin for the next generation
title_full Aspirin for the next generation
title_fullStr Aspirin for the next generation
title_full_unstemmed Aspirin for the next generation
title_short Aspirin for the next generation
title_sort aspirin for the next generation
topic Conference Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622499/
https://www.ncbi.nlm.nih.gov/pubmed/23589729
http://dx.doi.org/10.3332/ecancer.2013.300
work_keys_str_mv AT hendersonnick aspirinforthenextgeneration
AT smithtom aspirinforthenextgeneration

Ejemplares similares